ISL1 Promotes Cancer Progression and Inhibits Cisplatin Sensitivity in Triple-Negative Breast Cancer Cells

International Journal of Molecular Medicine - Greece
doi 10.3892/ijmm.2018.3842
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Modeling of Cisplatin-Induced Signaling Dynamics in Triple-Negative Breast Cancer Cells Reveals Mediators of Sensitivity

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin

Oncotarget
Oncology
2014English

Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells

Pharmaceutics
Pharmaceutical Science
2018English

FZD7 in Triple Negative Breast Cancer Cells

2011English

Curcumin Restores Sensitivity to Retinoic Acid in Triple Negative Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Downregulation of RIP140 in Triple‑negative Breast Cancer Inhibits the Growth and Proliferation of Cancer Cells

Oncology Letters
Cancer ResearchOncology
2018English

miR-29b-3p Promotes Progression of MDA-MB-231 Triple-Negative Breast Cancer Cells Through Downregulating TRAF3

Biological Research
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgricultural
2019English

HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells

PLoS ONE
Multidisciplinary
2013English

Triple-Negative Breast Cancer

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy